Clinical Trial Update: Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids [Phase 3]

View source ↗

Summary

Phase 3 trial update on pilocarpine for dry mouth due to opioid use; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Complications
• Quality of Life

Drugs mentioned

• Pilocarpine (pilocarpine)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Oral Complications, Quality of Life | Phase 3 | Status: TERMINATED